Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18009071 | PROCESS FOR PRODUCING CARRIER PARTICLES FOR THE CULTIVATION OF BIOLOGICAL CELLS, CARRIER PARTICLES AND THEIR USE | Final Rejection | Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e. V. |
| 17774834 | EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS | Non-Final OA | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
| 17627229 | METHODS AND COMPOSITIONS FOR GENE DELIVERY | Non-Final OA | President And Fellows Of Harvard College |
| 18246087 | NOVEL ENHANCED BASE EDITING OR REVISING FUSION PROTEIN AND USE THEREOF | Final Rejection | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18017690 | CELL LINES FOR RECOMBINANT AAV PRODUCTION AND AAV-IMPLEMENTED PROTEIN PRODUCTION | Final Rejection | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18042726 | VIRAL VECTORS ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES | Final Rejection | The Trustees of the University of Pennsylvania |
| 17632063 | TARGETED GENE THERAPY TO TREAT NEUROLOGICAL DISEASES | Non-Final OA | Cornell University |
| 18170296 | COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY | Non-Final OA | The University of Hong Kong |
| 18549948 | Noninvasive AAV Vectors For Highly Efficient Gene Delivery To The Nervous System | Non-Final OA | Temple University-Of The Commonwealth System of Higher Education |
| 18551385 | EX-VIVO PROLIFERATION OF HUMAN PHAGOCYTIC CELLS | Non-Final OA | INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) |
| 18286709 | RATIONAL POLYPLOID AAV VIRIONS THAT CROSS THE BLOOD BRAIN BARRIER AND ELICIT REDUCED HUMORAL RESPONSE | Non-Final OA | ASKBIO INC. |
| 17907229 | INDUCIBLE PROMOTER FOR VIRAL VECTOR PRODUCTION | Final Rejection | ASKBIO INC. |
| 18266464 | GENOMIC EDITING OF COMPLEMENT | Non-Final OA | Apellis Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy